188 related articles for article (PubMed ID: 16381384)
1. [Remarkably low blood pressure induced by combination of SSRI and a small dose of TCA].
Onishi Y; Kato S; Kobayashi T; Kinuta T; Hirai N
Seishin Shinkeigaku Zasshi; 2005; 107(10):1034-9. PubMed ID: 16381384
[TBL] [Abstract][Full Text] [Related]
2. Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients.
Rodriguez de la Torre B; Dreher J; Malevany I; Bagli M; Kolbinger M; Omran H; Lüderitz B; Rao ML
Ther Drug Monit; 2001 Aug; 23(4):435-40. PubMed ID: 11477329
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants.
Perry PJ
J Affect Disord; 1996 Jun; 39(1):1-6. PubMed ID: 8835647
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
Pollok J; van Agteren JE; Carson-Chahhoud KV
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235
[TBL] [Abstract][Full Text] [Related]
5. Increased rate of trazodone prescribing with bupropion and selective serotonin-reuptake inhibitors versus tricyclic antidepressants.
Clark NA; Alexander B
Ann Pharmacother; 2000 Sep; 34(9):1007-12. PubMed ID: 10981245
[TBL] [Abstract][Full Text] [Related]
6. Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures.
Ziere G; Dieleman JP; van der Cammen TJ; Hofman A; Pols HA; Stricker BH
J Clin Psychopharmacol; 2008 Aug; 28(4):411-7. PubMed ID: 18626268
[TBL] [Abstract][Full Text] [Related]
7. A comparison of side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants in older depressed patients: a meta-analysis.
Wilson K; Mottram P
Int J Geriatr Psychiatry; 2004 Aug; 19(8):754-62. PubMed ID: 15290699
[TBL] [Abstract][Full Text] [Related]
8. Selective serotonin reuptake inhibitors and tricyclic antidepressants in combination. Interactions and therapeutic uses.
Taylor D
Br J Psychiatry; 1995 Nov; 167(5):575-80. PubMed ID: 8564311
[TBL] [Abstract][Full Text] [Related]
9. Prognosis in heart failure and the value of {beta}-blockers are altered by the use of antidepressants and depend on the type of antidepressants used.
Fosbøl EL; Gislason GH; Poulsen HE; Hansen ML; Folke F; Schramm TK; Olesen JB; Bretler DM; Abildstrøm SZ; Sørensen R; Hvelplund A; Køber L; Torp-Pedersen C
Circ Heart Fail; 2009 Nov; 2(6):582-90. PubMed ID: 19919983
[TBL] [Abstract][Full Text] [Related]
10. Influence of initial use of serotonergic antidepressants on antiparkinsonian drug use in levodopa-using patients.
Arbouw ME; Movig KL; Neef C; Guchelaar HJ; Egberts TC
Eur J Clin Pharmacol; 2007 Feb; 63(2):181-7. PubMed ID: 17200834
[TBL] [Abstract][Full Text] [Related]
11. Cardiac disorders and antidepressant medications.
Murray JB
J Psychol; 2000 Mar; 134(2):162-8. PubMed ID: 10766108
[TBL] [Abstract][Full Text] [Related]
12. Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose.
Vestergaard P; Prieto-Alhambra D; Javaid MK; Cooper C
Osteoporos Int; 2013 Feb; 24(2):671-80. PubMed ID: 22669469
[TBL] [Abstract][Full Text] [Related]
13. Does the use of SSRIs reduce medical care utilization and expenditures?
Chung S
J Ment Health Policy Econ; 2005 Sep; 8(3):119-29. PubMed ID: 16278500
[TBL] [Abstract][Full Text] [Related]
14. Risk of fractures with selective serotonin-reuptake inhibitors or tricyclic antidepressants.
Ginzburg R; Rosero E
Ann Pharmacother; 2009 Jan; 43(1):98-103. PubMed ID: 19116378
[TBL] [Abstract][Full Text] [Related]
15. General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction.
Tata LJ; West J; Smith C; Farrington P; Card T; Smeeth L; Hubbard R
Heart; 2005 Apr; 91(4):465-71. PubMed ID: 15772201
[TBL] [Abstract][Full Text] [Related]
16. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability.
Qin B; Zhang Y; Zhou X; Cheng P; Liu Y; Chen J; Fu Y; Luo Q; Xie P
Clin Ther; 2014 Jul; 36(7):1087-1095.e4. PubMed ID: 24998011
[TBL] [Abstract][Full Text] [Related]
17. Assessment of adverse drug reactions in psychiatric inpatients with the AMSP drug safety program: methods and first results for tricyclic antidepressants and SSRI.
Grohmann R; Rüther E; Engel RR; Hippius H
Pharmacopsychiatry; 1999 Jan; 32(1):21-8. PubMed ID: 10071179
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant drugs and the cardiovascular system: a comparison of tricylics and selective serotonin reuptake inhibitors and their relevance for the treatment of psychiatric patients with cardiovascular problems.
Coupland N; Wilson S; Nutt D
J Psychopharmacol; 1997; 11(1):83-92. PubMed ID: 9097898
[No Abstract] [Full Text] [Related]
19. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview.
Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I
Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236
[TBL] [Abstract][Full Text] [Related]
20. Association of Antidepressant Medications With Incident Type 2 Diabetes Among Medicaid-Insured Youths.
Burcu M; Zito JM; Safer DJ; Magder LS; dosReis S; Shaya FT; Rosenthal GL
JAMA Pediatr; 2017 Dec; 171(12):1200-1207. PubMed ID: 29049533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
